POS0409 IMPROVEMENTS IN CD163, A URINARY BIOMARKER OF RENAL INFLAMMATION, WITH ANIFROLUMAB: RESULTS FROM A PHASE 2 TRIAL IN LUPUS NEPHRITIS

Ferrari N., Fava A., Petri M., Gavin P.G., Csomor E.,Brohawn P.Z.,Muthas D.,Platt A.,Lindholm C.

Annals of the Rheumatic Diseases（2024）

Cited 0|Views2

Key words

Kidneys,Biomarkers,Randomized controlled trial,Cytokines and Chemokines,Clinical Trial

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined